Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 18, 2021
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
Tue, August 17, 2021
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
[ Tue, Aug 17th 2021
] - WOPRAI
Joseph Schwartz Maintained (TVTX) at Buy with Increased Target to $37 on, Aug 17th, 2021
Joseph Schwartz of SVB Leerink, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $27 to $37 on, Aug 17th, 2021.
Joseph has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $19 on, Wednesday, May 26th, 2021
This is the rating of the analyst that currently disagrees with Joseph
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $45 on, Thursday, May 27th, 2021
